Fagron announces today the acquisition of Brazilian Alternate Technologies, the leading developer and supplier of innovative software and technology tools for pharmaceutical compounding. Over 3,500 Brazilian pharmacies and prescribers daily use the state-of-the-art software tools for pharmaceutical compounding and the prescription software for tailor-made medication of Alternate. Alternate Technologies is expected to achieve a turnover of approximately 11 million Brazilian real in 2013 with an EBITDA-margin above the average for the Fagron Group. Alternate Technologies is consolidated as from 1 October 2013.
Ger van Jeveren, CEO of Fagron: "We are delighted to welcome Alternate Technologies to the Fagron Group. This acquisition plays an essential role in our strategy to strengthen our global market leadership in pharmaceutical compounding and to further optimise our total compounding solution for our 200,000 customers worldwide with the added-value software and technology tools of Alternate Technologies. Due to the excellent track record and the quality of the organisation of both Alternate Technologies and Fagron, we expect a rapid and smooth integration."
Marco Perino, President of Alternate Technologies: "I am looking forward to combining forces with the Fagron Group. Fagron's global and rapidly expanding network offers great potential to introduce our successful and unique technology and software solutions globally. Our employees will enjoy opportunities for further development in an international environment. Further, I look forward to the opportunity of contributing to the future growth and expansion of both Alternate Technologies and the Fagron Group."